Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations.

Fukuda K, Takeuchi S, Arai S, Nanjo S, Sato S, Kotani H, Kita K, Nishiyama A, Sakaguchi H, Ohtsubo K, Yano S
Cell Rep Med. 2024 Jun 18;5(6):101578. doi: 10.1016/j.xcrm.2024.101578. Epub 2024 May 21. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.